GlassScriptPhysician profile
Patrick G Burke
NPI 1053462820
$2,127.24
in general payments reported to CMS, 2019-2025
18 companies · $354 in 2025
The $354 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $80.31 · 2022: $181 · 2023: $316 · 2024: $603 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $312.80 | 2019-2025 | |
| Pfizer INC. | $279.68 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $252.31 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $244.18 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Kaleo, INC. | $235.21 | 2019-2024 | Auvi-Q |
| Cranial Technologies, INC | $141.39 | 2022-2025 | Doc Band |
| Sobi, INC | $130.91 | 2019-2023 | |
| Abbvie INC. | $123.28 | 2019-2024 | Lupron Depot |
| Seqirus USA INC | $114.08 | 2019-2025 | Flucelvax |
| Astrazeneca Pharmaceuticals LP | $62.87 | 2023-2024 | Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $42.65 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.35 | 2019-2020 | |
| Alk-Abello, INC | $38.03 | 2025 | Neffy, Odactra, Ragwitek |
| Regeneron Healthcare Solutions, INC. | $37.47 | 2023 | Dupixent |
| Roche Diagnostics Corporation | $21.25 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $19.30 | 2024 | |
| Phadia US INC. | $16.84 | 2025 | Immunocap |
| Vertical Pharmaceuticals, LLC | $15.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.